The incidence of proven/probable invasive candidiasis in the placebo and caspofungin arms was 16.7 % ( 14/84 ) and 9.8 % ( 10/102 ) , respectively , for prophylaxis ( P = .14 ) , and 30.4 % ( 31/102 ) and 18.8 % ( 22/117 ) , respectively , for the preemptive approach ( P = .04 ) ; however , this analysis included patients with baseline disease .